Ipilimumab vs Trimethoprim

## Ipilimumab vs Trimethoprim: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Trimethoprim**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Trimethoprim**: Dihydrofolate reductase inhibitor (bacterial selective).

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Trimethoprim — 8-10 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Trimethoprim — C14H18N4O3.

**Molecular Weight**: Ipilimumab — N/A; Trimethoprim — 290.3180 g/mol.

**Type**: Ipilimumab — Antibody; Trimethoprim — Small molecule.